En español
NIDA

Menu

Suboxone® (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules

Suboxone Buprenorphine/Naloxone Taper

This study was undertaken to compare, in an outpatient setting, the relative advantage of two Suboxone® (Bup/Nx) tapering schedules (one rapid and one gradual) following four weeks of Suboxone® stabilization, as reflected by the proportion of participants providing opiate free urines at the end of the taper regimen. In total, 516 participants were randomized to one of two taper schedules, either 7 days or 28 days. The reason for conducting this study was not to advocate for short-term treatment, but to determine the relative ease of using a more rapid vs. a gradual taper should someone need to discontinue Bup/Nx.

CTN Protocol ID: 
CTN-0003
DSMB ID: 
3
Enrollment Status: 
Completed
ClinicalTrials.gov ID: 
Primary Outcomes Article: 

Ling, W., et al. (2009).  Buprenorphine tapering schedule and illicit opioid use.  Addiction 104: 256-265.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150159/

Principal Investigator(s)
Walter Ling, M.D.
Director
Integrated Substance Abuse Programs
University of California, Los Angeles
11075 Santa Monica Boulevard
Suite 200
Los Angeles, CA 90025
lwalter@ucla.edu

Available Brochures

Get this Publication

    Blending Initiative

    blending logo

    Formed with SAMHSA to reduce the gap between research results and treatment.